|
Re: RVX FILES ANNUAL INFO FORM
|
4
|
Resverlogix Corp.
|
Jul 28, 2015 09:29AM
|
|
Re: Zacks Buy Ranking
|
4
|
Resverlogix Corp.
|
Nov 04, 2015 12:42PM
|
|
F6 at IV
|
4
|
Resverlogix Corp.
|
Sep 18, 2017 01:11PM
|
|
Re: got filled..
|
4
|
Resverlogix Corp.
|
Sep 18, 2019 11:33AM
|
|
Re: Trillium
|
4
|
Zenith Epigenetics
|
Aug 26, 2021 11:11AM
|
|
Re: September 24th.
|
4
|
Resverlogix Corp.
|
Sep 24, 2021 02:16PM
|
|
Re: Shareholders Meeting
|
4
|
Resverlogix Corp.
|
Jul 09, 2024 07:29AM
|
|
Chinese Perspective
|
4
|
Resverlogix Corp.
|
Jun 08, 2015 09:17AM
|
|
Re: Apropos AGM
|
4
|
Resverlogix Corp.
|
Jun 08, 2022 06:22PM
|
|
Re: FDA approves drug that reduces MACE in Diabetes patients (Forbes)
|
3
|
Resverlogix Corp.
|
Jun 15, 2016 11:31AM
|
|
Re: ... unfinished business
|
3
|
Zenith Epigenetics
|
Oct 31, 2018 02:39PM
|
|
Re: Question on Rosuvastatin versus Astorvastatin
|
3
|
Resverlogix Corp.
|
Sep 09, 2019 06:04PM
|
|
Re: From the floor at AGM
|
3
|
Resverlogix Corp.
|
Sep 13, 2018 12:22PM
|
|
Re: Question on Rosuvastatin versus Astorvastatin
|
3
|
Resverlogix Corp.
|
Sep 09, 2019 06:24PM
|
|
Re: What's going on with the Phase 2 ZEN-3694 mCRPC trial?
|
3
|
Zenith Epigenetics
|
Jul 26, 2019 02:59PM
|
|
Re: What's going on with the Phase 2 ZEN-3694 mCRPC trial?
|
3
|
Zenith Epigenetics
|
Jul 26, 2019 03:07PM
|
|
Re: Looks like 0 participation in warrant incentive imo - answer to my email...
|
3
|
Resverlogix Corp.
|
Jan 27, 2020 12:09PM
|
|
Long Term Share Price Trend
|
3
|
Resverlogix Corp.
|
Jul 31, 2024 10:21AM
|
|
Re: Zenith Epigenetics Announces Clinical Trial Collaboration with Pfizer
|
3
|
Zenith Epigenetics
|
Nov 21, 2018 03:32PM
|
|
Advice
|
3
|
Resverlogix Corp.
|
Nov 19, 2021 11:50AM
|
